All Articles

A look at how a national car wash chain’s local renovations in Kentucky are part of a larger corporate reset, blending high-tech service with deep community ties.

With a proven record in biosimilars, new President Dominic Bégin is set to deepen Organon's impact on women's health and healthcare affordability in Canada.

A new alliance between Pentera and Recorded Future bridges the critical gap between threat intelligence and security validation, turning data into defense.

IDC names SPS a leader, but the real story is how AI and integrated strategy are turning the humble mailroom into a strategic hub for global business.

A new AI tool is replacing spreadsheets, helping firms make faster, data-backed decisions on when to replace vehicles, saving millions in the process.

Beyond the headlines of a dramatic profit swing, Healthcare Services Group's Q2 results reveal a playbook on operational mastery and shrewd capital deployment.

As prediction markets boom to $44B monthly, most trades are illiquid. Intellistake's strategic pivot with its Gravity tech aims to fix this deep-seated issue.

When a hospital's diagnostic system fails, the cost is human. A $2.1M verdict reveals how a breakdown in this invisible network led to a preventable death.

With an oversubscribed $130M Series B, Crystalys Therapeutics is accelerating its gout drug, dotinurad. But can it win the race to serve millions?

With 61% of its students being the first in their families to attend college, Goodwin's new initiatives offer more than support—they offer a national blueprint.

In a strategic power play, NOVAGOLD is taking full ownership of Donlin Gold, forming a new US-based titan to develop America's largest gold mine.

A new partnership between Evogene and ELEO leverages AI and natural product science to create an oral PCSK9 inhibitor, aiming to disrupt a $23B market.

By appointing its first Chief People Officer from the world of high-growth retail, Spear Therapy is betting that employee experience is the key to scaling patient care. Here’s the strategic rationale.

Stearns & Foster, a brand synonymous with handcrafted luxury since 1846, is betting its future on a fusion of heritage and science. Is this the answer to our sleep crisis?

A new AI-driven test from BRAINBox Solutions combines blood analysis and cognitive data, promising to finally replace guesswork in concussion diagnosis.

As ACCO Brands preps its Q2 report, investors seek clues on hybrid work, gaming, and back-to-school trends. Can strategic acquisitions offset economic headwinds?

As Frontier prepares its Q2 results, a strategic shift is underway. Can First Class seats and Wi-Fi coexist with an ultra-low-cost model? All eyes are on ULCC.

As TuHURA Biosciences takes the stage at a key investor conference, its multi-pronged attack on immunotherapy resistance faces a critical test.

As Premium Brands preps its Q2 results, investors are watching if its U.S. acquisition strategy can offset seafood struggles and inflationary pressures.

With $8M in new funding, Tikva Allocell is advancing a novel cell therapy that uses armored, virus-specific T cells to overcome historical barriers in cancer.